Methylation status of DDIT3 gene in chronic myeloid leukemia

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Wang, Ya Li ^a   Qian, Jun ^a   Lin, Jiang ^a   Yao, Dong Ming ^a   Qian, Zhen ^a   Zhu, Zhao Hui ^a   Li, Jian Yong ^b  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; DDIT3 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; BCR ABL GENE; BMMNC CELL LINE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATIONAL STUDY; DDIT3 GENE; DNA METHYLATION; FEMALE; GENDER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PLATELET COUNT; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, WESTERN; DNA METHYLATION; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 77952449082     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-54     Document Type: Article

References (20)

1. Quintás-Cardama A, Cortes JE: Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 2006, 81:973-988.
2. Melo JV, Barnes DJ: Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007, 7: 441-453.
3. Calabretta B, Perrotti D: The biology of CML blast crisis. Blood 2004, 103:4010-4022.
4. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168-174.
5. Esteller M: Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005, 45:629-656.
6. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB: The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996, 56: 973-977.
7. Qian J, Wang YL, Lin J, Yao DM, Xu WR, Wu CY: Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG inland in chronic myeloid leukemia. Eur J Haematol 2009, 82:119-123.
8. Melki JR, Vincent PC, Brown RD, Clark SJ: Hypermethyation of E-cadherin in leukemia. Blood 2000, 95: 3208-3213.
9. Herman JG, Civin CI, Issa JP, Collector MI, Skarkis SJ, Baylin SB: Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997, 57: 837-841.
10. Maytin EV, Habener JF: Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 1998, 110:238-246.
11. Tang QQ, Lane MD: Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Proc Natl Acad Sci USA 2000, 97:12446-12450.
12. Pereira RC, Delany AM, Canalis E: CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 2004, 145:1952-1960.
13. Coutts M, Cui K, Davis KL, Keutzer JC, Sytkowski AJ: Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation. Blood 1999, 93:3369-3378.
14. Friedman AD: GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res 1996, 56:3250-3256.
15. Matsumoto M, Minami M, Takeda K, Sakao Y, Akira S: Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett 1996, 395:143-147.
16. Qian J, Chen Z, Lin J, Wang W, Cen J: Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases. Leuk Res 2005, 29:1435-1441.
17. Agrawal S, Hofmann WK, Tidow N, Ehrich M, Boom D van den, Koschmieder S, Berdel WE, Serve H, Müller-Tidow C: The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 2007, 109:3895-3905.
18. Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko- Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M, Marcucci G, Bloomfield CD, Plass C: Epigenetic modification of CCAAT/enhancer binding protein A expression in acute myeloid leukemia. Cancer Res 2008, 68:3142-3151.
19. Jost E, do ON, Wilop S, Herman JG, Osieka R, Galm O: Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia. Leuk Res 2009, 33:443-449.
20. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylationspecific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826.